首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >Efficacy of Sodium Hypochlorite in Eradicating Hepatitis C Virus (HCV)-RNA from the Peritoneal Effluent of PD Patients.
【24h】

Efficacy of Sodium Hypochlorite in Eradicating Hepatitis C Virus (HCV)-RNA from the Peritoneal Effluent of PD Patients.

机译:次氯酸钠在PD患者腹膜排出的根除丙型肝炎病毒(HCV)-RNA中的功效。

获取原文
获取原文并翻译 | 示例
       

摘要

Hepatitis C virus (HCV) constitutes an important health problem among the population with chronic renal failure: in 15% - 20% according to various studies (1-8). Although different routes of transmission have been described, in an important number of patients the source of infection remains unknown. Peritoneal dialysis (PD) has been suggested as a better option than hemodialy-sis for dialysis in patients with HCV. Nevertheless, some 2% - 5% of patients treated with PD demonstrate serum antibodies against HCV. Although it is possible to find HCV in corporal fluids, even ascites (9), there are very few studies in PD patients on the risk of dissemination of HCV-RNA through the peritoneal effluent (10-15), and the conclusions of the aforementioned studies are contradictory. There are no published data on the eradication of HVC-RNA from the peritoneal effluent.
机译:丙型肝炎病毒(HCV)在患有慢性肾功能衰竭的人群中构成了重要的健康问题:根据各种研究(1-8),这一比例在15%-20%之间。尽管已经描述了不同的传播途径,但是在许多患者中,感染的来源仍然未知。对于HCV患者,腹膜透析(PD)已被推荐为比血液透析更好的选择。然而,PD治疗的患者中约有2%-5%表现出抗HCV的血清抗体。尽管有可能在体液,甚至腹水中发现HCV(9),但在PD患者中很少有关于通过腹膜流出液传播HCV-RNA的风险的研究(10-15),以及上述结论研究是矛盾的。目前尚无有关从腹膜流出物中清除HVC-RNA的公开数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号